Balancing Innovation With Cost in Diagnostic Testing
As clinical targets in more common malignancies emerge, testing and treatment options will increase. Balancing these choices with the high costs of new technology will be the challenge to ensure value in oncology care.
Future of Myopia Involves Catching It Earlier, Utilizing New Technologies
Advancing Care for Dry Eye and Corneal Conditions
Enhancing Retinal Disease Outcomes With Anti-VEGF Therapies
Multimodal Imaging Can Be Used to Manage AMD
